Table 4.
Author-year | Intervention | Death, n/total | Major bleeding, n/total | Major thrombotic events, n (%) | Any bleeding, n (%) | VTE, n (%) | Any thrombotic events, n (%) |
---|---|---|---|---|---|---|---|
Castelnuovo-2021 [28] | TA | 62/418 | / | / | / | / | / |
PA | 114/983 | / | / | / | / | / | |
Elmelhat-2020 [29] | TA | 3/39 | 3/39 | / | 3 (7.7) | / | / |
PA | 0/20 | 0/20 | / | 0 (0) | / | / | |
Gonzalez-Porras-2021 [30] | TA | 57/120 | 6/120 | 3 | / | / | / |
PA | 134/410 | 8/410 | 7 | / | / | / | |
Hamad-2021 [31] | TA | 11/29 | 6/29 | / | / | / | / |
PA | 6/17 | 2/17 | / | / | / | / | |
Helms-2021 [32] | TA | 11/71 | / | 15 (21.1) | / | / | / |
PA | 20/108 | / | 42 (38.9) | / | / | / | |
Martinelli-2020 [33] | TA | 24/127 | 4/127 | / | / | / | / |
PA | 50/151 | 0/151 | / | / | / | / | |
Battistoni-2021 [34] | TA | 27/102 | 9/102 | / | / | / | / |
PA | 105/550 | 47/550 | / | / | / | / | |
Ionescu-2020 [8] | TA | 236/998 | 81/998 | / | / | / | / |
PA | 229/2121 | 46/2121 | / | / | / | / | |
Kaur-2020 [35] | TA | 109/381 | / | / | / | / | / |
PA | 132/652 | / | / | / | / | / | |
Canoglu-2020 [35] | TA | 10/56 | / | / | / | / | / |
PA | 44/98 | / | / | / | / | / | |
Qin-2021 [37] | TA | 25/77) | / | / | / | / | / |
PA | 19/109 | / | / | / | / | / | |
Matli-2021 [38] | TA | 7 /31 | 2/31 | / | / | / | 9 (38.7) |
PA | 5/51 | 2/51 | / | / | / | 5 (9.8)/ | |
Mennuni-2021 [39] | TA | 40/149 | 1/149 | 1 (4.8) | / | 19 (12.8) | / |
PA | 73/287 | 1/287 | 1 (1.5) | / | 3 (1.1) | / | |
Kodama-2020 [40] | TA | 38/82 | 7/70 | / | / | / | / |
PA | 149/498 | 16/458 | / | / | / | / | |
Jonmarker-2020 [41] | TA | 5/37 | 1/37 | / | / | / | / |
PA | 26/67 | 8/67 | / | / | / | / | |
Takayama-2021 [42] | TA | 0/33 | / | 9/29. | / | 1 (3.0) | 0 (0) |
PA | 5/29 | / | 1/33 | / | 4(13.8) | 0 (0) | |
Yu-2021 [43] | TA | 163/298 | 41/298 | / | / | / | / |
PA | 298/979 | 35/979 | / | / | / | / |
Abbreviations: VTE Venous thromboembolism, TA Therapeutic anticoagulation, PA Prophylactic anticoagulation